X-Therma

2:30 PM - 2:45 PM, Tuesday, October 22, 2019 ・ 2nd Floor
800,000 deaths per year could be preventable by organ transplants, but fewer than 37,000 transplants are done early. Shockingly, 80% of transplantable organs are wasted. The main reason: we can preserve organs for a few hours only, which is hardly enough time to get from donor to patient without functional deterioration.
X-Therma has developed a biomimetic cryoprotectant material that enables long term sub-zero storage of organs while preserving viability and functionality for transplant. Our goal is to enable greatly extended preservation times, going from hours to - months.
According to the US Department of Defense, we may be able to abolish some waiting lists in as little as a couple of years. Better preservation enabled by X-Therma will not only result in many more organs available for transplant and thus lives saved, but also "better organs". Halting ischemic damage results in enhanced graft viability and faster recovery, and thus drastically shorter hospital stays.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
XT-VIVO
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO
X-Therma